https://www.openbell.ai/ 2026-10-30T08:50:05.508Z hourly 1.0 https://www.openbell.ai/support 2026-10-30T08:50:05.508Z monthly 0.7 https://www.openbell.ai/privacy 2026-10-30T08:50:05.508Z monthly 0.5 https://www.openbell.ai/terms 2026-10-30T08:50:05.508Z monthly 0.5 https://www.openbell.ai/feed.json 2026-10-30T08:50:05.508Z hourly 0.8 https://www.openbell.ai/news/SUNPHARMA:1793349175000 2026-10-30T08:32:55.000Z daily 0.9 https://cdn.brandfetch.io/SUNPHARMA/w/400/h/400?c=1idopYfmtR7ZKg8QMud Sun Pharma Receives US FDA Approval for ILUMYA in Psoriatic Arthritis Sun Pharmaceutical Industries received US FDA approval for ILUMYA (tildrakizumab-asmn) to treat psoriatic arthritis, expanding the drug’s use beyond existing dermatological conditions. The approval strengthens the company’s US specialty portfolio; commercial rollout details and eligible patient populations were not disclosed. The announcement provided no financial figures or stock-market impact. https://www.openbell.ai/news/8035:1793349142000 2026-10-30T08:32:22.000Z daily 0.9 https://cdn.brandfetch.io/8035/w/400/h/400?c=1idopYfmtR7ZKg8QMud Tokyo Electron Reports Higher First-Half Net Income and Sales Tokyo Electron reported higher attributable net income and net sales in the first half of its fiscal year. The article provides no specific financial figures or growth rates and reports no strategic changes or stock-market impact. https://www.openbell.ai/news/6503:1793349140000 2026-10-30T08:32:20.000Z daily 0.9 https://cdn.brandfetch.io/6503/w/400/h/400?c=1idopYfmtR7ZKg8QMud Mitsubishi Electric Reports Higher Fiscal H1 Profit and Revenue Mitsubishi Electric reported higher revenue and attributable profit for the first half of its fiscal year. Building Systems adjusted operating profit rose to ¥18.8 billion from ¥14.2 billion a year earlier, while Automotive Equipment adjusted operating profit increased to ¥21.7 billion from ¥11.8 billion. The report did not provide overall revenue or profit figures or mention a stock-price reaction. https://www.openbell.ai/news/AMP:1793349118000 2026-10-30T08:31:58.000Z daily 0.9 https://cdn.brandfetch.io/AMP/w/400/h/400?c=1idopYfmtR7ZKg8QMud Amplifon Reports Strong Profit Growth Amplifon reported a notable increase in profit, with its results highlighted in market reports on October 30, 2026, after figures were released the previous evening. The article provides no specific revenue, profit, or growth figures and reports no stock-price movement or strategic changes. https://www.openbell.ai/news/ACX:1793349117000 2026-10-30T08:31:57.000Z daily 0.9 https://cdn.brandfetch.io/ACX/w/400/h/400?c=1idopYfmtR7ZKg8QMud Acerinox Reports Significant Profit Growth for First Nine Months of 2026 Acerinox reported net profit of €162 million for the first nine months of 2026, up 23-fold from €7 million in the same period of 2025. The Madrid-based stainless steel and high-performance alloys manufacturer also reported EBITDA, but the article did not provide its amount. https://www.openbell.ai/news/CABK:1793349115000 2026-10-30T08:31:55.000Z daily 0.9 https://cdn.brandfetch.io/CABK/w/400/h/400?c=1idopYfmtR7ZKg8QMud CaixaBank Reports 9M26 Financial Results and Capital Allocation Updates CaixaBank reported net profit of €4.96 billion for the first nine months of 2026, up 12.9% year over year, supported by growth in lending and fee-related services. Its board approved an interim dividend of €1.28 billion and extended the ongoing share buyback program by three months. The report did not specify a stock-price reaction. https://www.openbell.ai/news/ASX:1793349113000 2026-10-30T08:31:53.000Z daily 0.9 https://cdn.brandfetch.io/ASX/w/400/h/400?c=1idopYfmtR7ZKg8QMud ASE Technology Announces Capacity Investment Strategy Following Record Q3 Results ASE Technology reported record third-quarter 2026 results, driven by demand for its LEAP (Leadframe-based Advanced Packaging) technology. The company said it will pursue an aggressive capacity investment strategy to support continued growth through 2027. The article did not provide specific financial figures or report a stock-price movement. https://www.openbell.ai/news/SNY:1793349109000 2026-10-30T08:31:49.000Z daily 0.9 https://cdn.brandfetch.io/SNY/w/400/h/400?c=1idopYfmtR7ZKg8QMud Sanofi Reports Q3 2026 Financial Results and Raises Full-Year Outlook Sanofi reported a 14.3% increase in third-quarter 2026 sales at constant exchange rates and business earnings per share of €3.55, supported by strong commercial momentum and Dupixent. The company raised its full-year outlook for the second time, now expecting sales growth in the low teens and business EPS growth in the mid teens, excluding currency effects. Its CEO said Sanofi is seeking potential acquisitions to strengthen its medicine pipeline ahead of upcoming patent expirations. https://www.openbell.ai/news/EBS:1793349108000 2026-10-30T08:31:48.000Z daily 0.9 https://cdn.brandfetch.io/EBS/w/400/h/400?c=1idopYfmtR7ZKg8QMud Erste Group Reports Q3 2026 Results and Raises 2026 Financial Outlook Erste Group reported net profit of EUR 3,095 million for the first three quarters of 2026 and raised its full-year outlook. It now expects return on tangible equity above 20% and earnings per share growth above 20%, while raising its annual loan-volume target to more than EUR 290 billion. The bank also forecasts net interest income growth above 6%, net fee and commission income growth of about 10%, and a cost-to-income ratio below 46% for 2026. https://www.openbell.ai/news/TRENT:1793349105000 2026-10-30T08:31:45.000Z daily 0.9 https://cdn.brandfetch.io/TRENT/w/400/h/400?c=1idopYfmtR7ZKg8QMud Trent Limited Reports Q2 Financial Results Trent Limited reported growth in consolidated revenue and profit in the fiscal second quarter. Its net profit for the first half of the fiscal year reached ₹986.16 crore. The report did not provide specific Q2 figures or mention stock-price movements or strategic changes. https://www.openbell.ai/news/PUM:1793349102000 2026-10-30T08:31:42.000Z daily 0.9 https://cdn.brandfetch.io/PUM/w/400/h/400?c=1idopYfmtR7ZKg8QMud PUMA SE Reports Q3 2026 Results and Updates Full-Year Outlook PUMA SE reported a 6.3% currency-adjusted sales decline in Q3 2026 and a net loss of €54.9 million, compared with a €62 million loss a year earlier, marking a second consecutive quarter of operating losses. Gross margin improved to 49.5%, while APAC sales grew 10.0%. The company narrowed its full-year 2026 EBIT loss outlook to €80 million–€130 million and cut planned capital investment to €150 million from €200 million, citing IT costs shifting to operating expenses and more targeted spending. https://www.openbell.ai/news/CAP:1793349098000 2026-10-30T08:31:38.000Z daily 0.9 https://cdn.brandfetch.io/CAP/w/400/h/400?c=1idopYfmtR7ZKg8QMud Capgemini Raises 2026 Revenue Growth Forecast Capgemini raised its 2026 revenue growth forecast on October 30, 2026, for the second time this year. The company cited sustained commercial momentum and strong third-quarter activity. It said AI remains a key growth driver as it targets enterprise demand for technology modernization. https://www.openbell.ai/news/SCR:1793349094000 2026-10-30T08:31:34.000Z daily 0.9 https://cdn.brandfetch.io/SCR/w/400/h/400?c=1idopYfmtR7ZKg8QMud SCOR Reports Third Quarter 2026 Financial Results SCOR reported third-quarter 2026 net profit of €206 million, above the €180 million analyst consensus but down from €217 million a year earlier. Reinsurance revenues rose 1.2% year over year to €3.76 billion, with P&C and Life & Health contributing nearly equally. The P&C combined ratio increased to 84.1% from 80.9%, reflecting higher claims, including a seismic event in Colombia, but remained below the company’s 87% target. Investment portfolio current yield improved to 4.1% from 3.5% in the third quarter of 2025. https://www.openbell.ai/news/286:1793347425000 2026-10-30T08:03:45.000Z daily 0.9 https://cdn.brandfetch.io/286/w/400/h/400?c=1idopYfmtR7ZKg8QMud NCTE AG Lowers 2026 Forecast and Announces Restructuring Program NCTE AG lowered its 2026 revenue forecast to €4.0 million–€4.2 million from €4.4 million–€5.4 million, and now expects EBITDA of -€1.1 million to -€0.9 million, versus its previous range of -€0.5 million to +€0.1 million. The company cited delayed revenue recognition from new orders and the non-renewal of framework contracts in the agricultural and e-bike sectors. Its board and supervisory board approved a cost-cutting restructuring program that will eliminate about one-third of the workforce, mainly in production and operations, while retaining core development, innovation, and direct sales functions. https://www.openbell.ai/news/EASY.B:1793347422000 2026-10-30T08:03:42.000Z daily 0.9 https://cdn.brandfetch.io/EASY.B/w/400/h/400?c=1idopYfmtR7ZKg8QMud EasyFill Reports Q3 2026 Interim Results EasyFill reported nearly flat revenue in Q3 2026, while revenue for the first nine months increased year over year. EBITDA improved and net loss narrowed compared with the year-earlier period. Liquidity remains a key pressure, and management is seeking a SEK 4.0 million bridge loan while aiming to expand existing U.S. and ITAB projects into larger-scale rollouts. https://www.openbell.ai/news/ALMAR:1793347419000 2026-10-30T08:03:39.000Z daily 0.9 https://cdn.brandfetch.io/ALMAR/w/400/h/400?c=1idopYfmtR7ZKg8QMud Groupe Mare Nostrum Reports 2026 First-Half Results Groupe Mare Nostrum reported first-half 2026 revenue of €44.1 million and a net loss of €2.1 million, half the pro forma loss in the first half of 2025. The company said revenue returned to growth in May and cited cost reductions and development of its Neptune RH Santé division as drivers of progress. Financial debt fell to €2.5 million from €3.8 million at the end of 2025, while equity improved to negative €1.7 million from negative €18.0 million in June 2025. Mare Nostrum also said it made the initial payments required under its continuation plans after the reporting period. https://www.openbell.ai/news/EVAX:1793347415000 2026-10-30T08:03:35.000Z daily 0.9 https://cdn.brandfetch.io/EVAX/w/400/h/400?c=1idopYfmtR7ZKg8QMud Evaxion Reports Phase II Results for EVX-01 in Advanced Melanoma Evaxion Biotech reported that its personalized neoantigen vaccine candidate EVX-01 achieved a 75% objective response rate in a Phase II study of patients with advanced melanoma when combined with pembrolizumab. The company said responses were durable and vaccine-induced T-cell activity was sustained, while noting the results came from a small study population. https://www.openbell.ai/news/XBRANE:1793347410000 2026-10-30T08:03:30.000Z daily 0.9 https://cdn.brandfetch.io/XBRANE/w/400/h/400?c=1idopYfmtR7ZKg8QMud Xbrane Biopharma Receives FDA Approval for Lucamzi™ Xbrane Biopharma said the FDA approved Lucamzi™, its biosimilar to Lucentis®, for retinal disorders including wet age-related macular degeneration. The company described the approval as a milestone for its commercial portfolio; the article reports no financial figures or stock-price impact. https://www.openbell.ai/news/MINEST:1793347396000 2026-10-30T08:03:16.000Z daily 0.9 https://cdn.brandfetch.io/MINEST/w/400/h/400?c=1idopYfmtR7ZKg8QMud Minesto Reports Q1–Q3 2026 Interim Results and Announces Planned Rights Issue Minesto reported an operating loss of SEK 23.3 million and operating income of SEK 16.3 million for the period ended September 30, 2026, with SEK 29.9 million in cash at period-end. The company plans a rights issue of approximately SEK 130 million to support development of its first commercial tidal energy farms; subscription undertakings and guarantees cover 60% of the offering. Minesto was also selected to enter grant agreement preparation with the European Commission for €20.2 million in funding for a 10 MW project in Ireland. https://www.openbell.ai/news/STECH:1793347392000 2026-10-30T08:03:12.000Z daily 0.9 https://cdn.brandfetch.io/STECH/w/400/h/400?c=1idopYfmtR7ZKg8QMud Soiltech ASA Reports Q3 2026 Financial Results and New Dividend Policy Soiltech ASA reported Q3 2026 revenue of NOK 131.7 million, up 30% year over year, and adjusted EBITDA of NOK 38.6 million, up 61%, with improved margins. Management plans to begin quarterly dividends in Q4 2026, targeting 30% of net profit after tax. The company also plans continued investment to support expected 2027 growth and expects Q4 results to be in line with Q3. https://www.openbell.ai/news/FEV:1793347388000 2026-10-30T08:03:08.000Z daily 0.9 https://cdn.brandfetch.io/FEV/w/400/h/400?c=1idopYfmtR7ZKg8QMud FORTEC Elektronik AG Publishes 2025/2026 Consolidated Financial Results FORTEC Elektronik AG reported fiscal 2025/2026 revenue of €81.2 million, above its forecast range of €76.0 million to €80.0 million. Consolidated EBIT was a loss of €0.7 million, better than the projected loss of €1.0 million to €1.5 million. The order backlog rose to approximately €54.6 million from €50.0 million a year earlier. Management plans to propose a dividend of €0.20 per share at the February 10, 2027 annual general meeting, citing the results and future financing needs. https://www.openbell.ai/news/GOD:1793347385000 2026-10-30T08:03:05.000Z daily 0.9 https://cdn.brandfetch.io/GOD/w/400/h/400?c=1idopYfmtR7ZKg8QMud Goodtech ASA Reports Q3 2026 Financial Results and New EPC Contract Goodtech ASA reported Q3 2026 net operating revenue after external project costs of 121.6 MNOK and EBITA of 8.5 MNOK. After-Sales and Service revenue rose 48%, reflecting a shift toward recurring, higher-margin business. After quarter-end, the company finalized an approximately 240 MNOK EPC contract for the Nussir copper project, which is expected to improve order backlog visibility. Investments in a new Kristiansand regional hub weighed on quarterly margins but are intended to expand engineering capacity and support growth. https://www.openbell.ai/news/TGAMES:1793347381000 2026-10-30T08:03:01.000Z daily 0.9 https://cdn.brandfetch.io/TGAMES/w/400/h/400?c=1idopYfmtR7ZKg8QMud Trophy Games Reports Q3 2026 Financial Results and Completion of Playrion Acquisition Trophy Games reported Q3 2026 revenue of DKK 47.5 million, up 19% year over year, with EBITDA rising 31% to DKK 10.0 million and EBIT increasing 44% to DKK 7.2 million. The company completed its acquisition of Paris-based Playrion SASU from Paradox Interactive on September 30, describing it as the largest acquisition in its history. Trophy Games maintained its 2026 full-year guidance, which was raised in September to reflect the acquisition, and cited improved player monetization and a strong product portfolio entering the final quarter. https://www.openbell.ai/news/ASPS:1793347379000 2026-10-30T08:02:59.000Z daily 0.9 https://cdn.brandfetch.io/ASPS/w/400/h/400?c=1idopYfmtR7ZKg8QMud Altisource Announces Third Quarter 2026 Financial Results Altisource Portfolio Solutions reported third-quarter 2026 service revenue of $49.8 million, up 26% year over year, with revenue from customers outside Onity and Rithm rising 96%. Adjusted EBITDA increased 17% to $4.3 million, while net loss improved to $1.4 million. The company cited customer-win ramp-ups and cost management, and reaffirmed its Project 45 target of $45 million in run-rate Adjusted EBITDA by the fourth quarter of 2028. https://www.openbell.ai/news/PYT:1793347375000 2026-10-30T08:02:55.000Z daily 0.9 https://cdn.brandfetch.io/PYT/w/400/h/400?c=1idopYfmtR7ZKg8QMud POLYTEC Holding AG Adjusts 2026 Earnings Forecast POLYTEC Holding AG lowered its 2026 EBIT margin forecast to 1%–2%, from around 3%, and expects sales of approximately €560 million, at the lower end of its previous guidance. The company cited fourth-quarter revenue fluctuations among major customers and ongoing operational effects from portfolio adjustments, including the closure of its Weierbach plant. It said profitability improved in the first half of 2026 and aims to raise non-automotive business to 30% of group sales within two to three years to reduce industry-specific volatility. https://www.openbell.ai/news/BINV:1793347374000 2026-10-30T08:02:54.000Z daily 0.9 https://cdn.brandfetch.io/BINV/w/400/h/400?c=1idopYfmtR7ZKg8QMud BioInvent Announces Proposed SEK 430 Million Rights Issue and Q3 2026 Results BioInvent proposed a rights issue of approximately SEK 430 million, subject to extraordinary general meeting approval, to fund priority clinical programs including BI-1808 and extend its cash runway through the end of 2027. For the first nine months of 2026, sales were lower than a year earlier, which included a $20 million mezagitamab rights payment; the company also reported reduced costs and SEK 225 million in liquid funds. BI-1808 combined with pembrolizumab achieved a 24% objective response rate and a 53% disease control rate in pretreated ovarian cancer, supporting plans for randomized triplet testing in 2027. https://www.openbell.ai/news/NETI.B:1793347365000 2026-10-30T08:02:45.000Z daily 0.9 https://cdn.brandfetch.io/NETI.B/w/400/h/400?c=1idopYfmtR7ZKg8QMud Net Insight AB Reports Q3 2026 Financial Results Net Insight AB reported Q3 2026 sales of SEK 104 million, down 29% year over year, mainly due to lower revenue in its Media segment. Sales rose 14% sequentially. The company cited new portfolio launches and customer acquisitions in Time Synchronization as signs of commercial progress, while prioritizing revenue conversion and gradual growth. https://www.openbell.ai/news/IBG:1793347355000 2026-10-30T08:02:35.000Z daily 0.9 https://cdn.brandfetch.io/IBG/w/400/h/400?c=1idopYfmtR7ZKg8QMud Iberpapel Reports Net Loss of 6.44 Million Euros for First Nine Months of 2026 Iberpapel Gestión reported a net loss of €6.44 million for the first nine months of 2026. The disclosure covers the company’s integrated forestry, pulp and paper business; no revenue, year-over-year comparison or stock-price impact was stated. https://www.openbell.ai/news/WWL:1793347350000 2026-10-30T08:02:30.000Z daily 0.9 https://cdn.brandfetch.io/WWL/w/400/h/400?c=1idopYfmtR7ZKg8QMud Wawel S.A. Reports Q3 2026 Financial Results Wawel S.A. reported Q3 2026 net profit of PLN 29.3 million, while revenue declined 2% year over year and operating profit rose 59%. Management cited cocoa prices, foreign exchange rates and seasonality as ongoing uncertainties. To manage input costs, the company has hedged cocoa for approximately 50% of its expected 2027 annual demand. https://www.openbell.ai/news/MLCHE:1793347338000 2026-10-30T08:02:18.000Z daily 0.9 https://cdn.brandfetch.io/MLCHE/w/400/h/400?c=1idopYfmtR7ZKg8QMud Cheops Technology Reports Fiscal Year 2025-2026 Financial Results For the fiscal year ended April 30, 2026, Cheops Technology reported revenue of €214.38 million, up 6.77%, and operating profit of €13.21 million, up 12.37%. Current result edged down 0.65% to €12.09 million, while net result fell 5.19% to €8.40 million, which the company attributed to specific provisions for debt depreciation. Cheops also highlighted iCod Private AI, a sovereign, multi-model AI offering run in its own datacenters. https://www.openbell.ai/news/TRIFOR:1793347332000 2026-10-30T08:02:12.000Z daily 0.9 https://cdn.brandfetch.io/TRIFOR/w/400/h/400?c=1idopYfmtR7ZKg8QMud Trifork Group Reports Q3 2026 Interim Results and Updates Financial Guidance Trifork Group reported 28% organic revenue growth and a 40% increase in adjusted EBITDA in Q3 2026 compared with the same period in 2025, driven by its Products segment and public sector engagements. The company narrowed its 2026 guidance to revenue of EUR 235–240 million, representing approximately 6–9% growth, and adjusted EBITDA of EUR 35–37 million, with a projected margin of 15–16%. https://www.openbell.ai/news/BSL:1793347331000 2026-10-30T08:02:11.000Z daily 0.9 https://cdn.brandfetch.io/BSL/w/400/h/400?c=1idopYfmtR7ZKg8QMud Basler AG Reports Preliminary 9-Month Results and Increases 2026 Forecast Basler AG reported preliminary results for the first nine months of 2026, citing sustained high incoming orders as a key performance driver. The company raised its financial forecast for the full 2026 fiscal year, though the announcement provided no specific revenue or profit figures. https://www.openbell.ai/news/PLT:1793347329000 2026-10-30T08:02:09.000Z daily 0.9 https://cdn.brandfetch.io/PLT/w/400/h/400?c=1idopYfmtR7ZKg8QMud poLight ASA Reports Q3 2026 Financial Results poLight ASA reported Q3 2026 revenue of NOK 4.9 million and an EBITDA loss of NOK 28.9 million. It ended the quarter with NOK 224.6 million in cash. The company reported two TLens design-ins in the consumer AR/MR sector, with one expected to launch in the near future. https://www.openbell.ai/news/INS:1793347328000 2026-10-30T08:02:08.000Z daily 0.9 https://cdn.brandfetch.io/INS/w/400/h/400?c=1idopYfmtR7ZKg8QMud Instone Real Estate Group SE Lowers 2026 Financial Forecast Instone Real Estate Group SE lowered its 2026 outlook, projecting sales of EUR 500 million to EUR 600 million, adjusted revenue of about EUR 450 million, and adjusted earnings after tax of EUR 25 million to EUR 30 million; it expects an adjusted gross margin above 28%. The company cited macroeconomic and political uncertainty, including third-quarter interest rate hikes that weakened investor demand. Some institutional transactions planned for 2026 have been deferred to the first quarter of 2027, while the planned dividend remains EUR 0.43 per share. https://www.openbell.ai/news/FUR:1793347327000 2026-10-30T08:02:07.000Z daily 0.9 https://cdn.brandfetch.io/FUR/w/400/h/400?c=1idopYfmtR7ZKg8QMud Fugro N.V. Reports Q3 2026 Financial Results Fugro N.V. reported 2.2% growth in comparable revenue in Q3 2026, while its adjusted EBIT margin declined to 5.2%. The company attributed the margin pressure to lower marine pricing, costs from Middle East disruptions, and Australian charter expenses; backlog fell 8.5%. Fugro maintained its full-year guidance and expects the offshore wind sector to recover from the second half of 2027. https://www.openbell.ai/news/XANO.B:1793347326000 2026-10-30T08:02:06.000Z daily 0.9 https://cdn.brandfetch.io/XANO.B/w/400/h/400?c=1idopYfmtR7ZKg8QMud XANO Industri AB Reports Third Quarter 2026 Financial Results XANO Industri AB reported third-quarter 2026 net sales of SEK 715 million, down 8.9% from SEK 785 million a year earlier. Operating profit fell to SEK 24 million from SEK 110 million, and the operating margin declined to 3.4% from 14.0%; adjusted operating profit was also SEK 24 million, compared with SEK 69 million. The company cited weak investment appetite among major customer groups and restructuring costs at Blowtech, while noting positive trends in Precision Technology and aftermarket services. XANO provided no quantified near-term forecast.